News tagged with amantadine
Amantadine is the organic compound known formally as 1-adamantylamine or 1-aminoadamantane. The molecule consists of adamantane backbone that has an amino group substituted at one of the four methyne positions. This pharmaceutical is sold under the name Symmetrel for use both as an antiviral and an antiparkinsonian drug. Rimantadine is a closely related derivative of adamantane with similar biological properties.
Apart from medical uses, this compound is useful as a building block, allowing the insertion of an adamantyl group.
According to the US Centers for Disease Control and Prevention, 100% of seasonal H3N2 and 2009 pandemic flu samples tested have shown resistance to adamantanes, and amantadine is no longer recommended for treatment of influenza. Additionally, its effectiveness as an antiparkinsonian drug is controversial, with a 2003 Cochrane Review concluding that it was ineffective for this purpose.
This text uses material from Wikipedia and is available under the GNU Free Documentation License.
(HealthDay)—Flu remains at epidemic proportions across the United States, but flu activity decreased in some areas during the second week of January, according to FluView, a weekly influenza surveillance ...
Diseases, Conditions, Syndromes Jan 19, 2013 | 4 / 5 (1) | 0
Multi-national clinical trial shows effectiveness of amantadine in treatment of traumatic brain injury
A multi-national study published today in the New England Journal of Medicine revealed a significant breakthrough in the treatment of patients in vegetative and minimally conscious states. The study showed that the drug a ...
Medical research Mar 12, 2012 | not rated yet | 0
Researchers are reporting the first treatment to speed recovery from severe brain injuries caused by falls and car crashes: a cheap flu medicine whose side benefits were discovered by accident decades ago.
Medical research Feb 29, 2012 | 5 / 5 (4) | 0